William Pickering
Stock Analyst at Bernstein
(1.78)
# 3,350
Out of 5,134 analysts
33
Total ratings
50%
Success rate
-1.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BEAM Beam Therapeutics | Maintains: Outperform | $37 → $41 | $27.49 | +49.15% | 2 | Jan 21, 2026 | |
| VRTX Vertex Pharmaceuticals | Upgrades: Outperform | n/a | $477.32 | - | 6 | Jan 12, 2026 | |
| BBIO BridgeBio Pharma | Initiates: Outperform | $94 | $75.85 | +23.93% | 1 | Dec 11, 2025 | |
| BHVN Biohaven | Downgrades: Market Perform | $34 → $9 | $11.48 | -21.60% | 3 | Nov 6, 2025 | |
| BIIB Biogen | Maintains: Market Perform | $155 → $157 | $195.62 | -19.74% | 1 | Nov 3, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $95 → $88 | $59.95 | +46.79% | 5 | Nov 3, 2025 | |
| NTLA Intellia Therapeutics | Downgrades: Market Perform | $14 → $15 | $12.22 | +18.66% | 2 | Oct 28, 2025 | |
| RNA Avidity Biosciences | Downgrades: Market Perform | $52 → $72 | $72.86 | -1.18% | 1 | Oct 27, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $753 → $781 | $793.53 | -1.58% | 3 | Aug 27, 2025 | |
| SRPT Sarepta Therapeutics | Initiates: Market Perform | $13 | $17.88 | -27.29% | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $314 → $310 | $332.61 | -6.80% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $27 → $24 | $63.69 | -62.32% | 2 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $81.33 | - | 2 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $6 | $2.16 | +177.78% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $53.17 | -17.25% | 1 | Mar 21, 2023 |
Beam Therapeutics
Jan 21, 2026
Maintains: Outperform
Price Target: $37 → $41
Current: $27.49
Upside: +49.15%
Vertex Pharmaceuticals
Jan 12, 2026
Upgrades: Outperform
Price Target: n/a
Current: $477.32
Upside: -
BridgeBio Pharma
Dec 11, 2025
Initiates: Outperform
Price Target: $94
Current: $75.85
Upside: +23.93%
Biohaven
Nov 6, 2025
Downgrades: Market Perform
Price Target: $34 → $9
Current: $11.48
Upside: -21.60%
Biogen
Nov 3, 2025
Maintains: Market Perform
Price Target: $155 → $157
Current: $195.62
Upside: -19.74%
BioMarin Pharmaceutical
Nov 3, 2025
Maintains: Outperform
Price Target: $95 → $88
Current: $59.95
Upside: +46.79%
Intellia Therapeutics
Oct 28, 2025
Downgrades: Market Perform
Price Target: $14 → $15
Current: $12.22
Upside: +18.66%
Avidity Biosciences
Oct 27, 2025
Downgrades: Market Perform
Price Target: $52 → $72
Current: $72.86
Upside: -1.18%
Regeneron Pharmaceuticals
Aug 27, 2025
Maintains: Outperform
Price Target: $753 → $781
Current: $793.53
Upside: -1.58%
Sarepta Therapeutics
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $17.88
Upside: -27.29%
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $332.61
Upside: -6.80%
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $63.69
Upside: -62.32%
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $81.33
Upside: -
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $2.16
Upside: +177.78%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $53.17
Upside: -17.25%